ARCHIVES

Report Doesn’t Quell Concerns About Duke Genomics Research, Biostatisticians Say

This article is from The Cancer Letter archive.

Vol. 36 No. 18 | May 14, 2010

Download PDF Visit The Full Archive

Related Articles

Doroshow: NCI Leaves It Up to Groups To Make Their Own Merger Deals

February 11, 2011

Funding opportunities listed.

February 27, 2004

HEW Finally Moves On Distribution Of Chemicals

September 7, 1979

FDA unlikely to pull Iressa from market. Iressa a case study in how not to develop a drug, ODAC member says.

April 1, 2005

NCI’s Chabner Cautions Against 3-Hour Taxol Infusion, May Lower Response Rate

October 22, 1993

FDA claims news coverage violated privacy of applicants for oncology job.

March 4, 2005